A Wall Street veteran recently declared that quantum computing is "more than a speculative bet." He's half right. The revenue data has moved beyond vaporware. The stock prices have moved past reasonable.
The disconnect isn't between hype and reality - it's between the narrative that this is now investable and the math that says every dollar of future success is already purchased.
1. IonQ is the only name with real revenue growth - and at 82 times trailing sales, the stock has priced in perfection.
IonQ (NYSE: IONQ) just reported Q1 2026 revenue of $64.7 million, up 755% year-over-year. For all of 2025, revenue hit $130 million - a 202% jump. Backlog - the contracted revenue already in the pipeline - surged to $470 million, up from $77 million a year ago. Analysts project revenue climbing to $638 million by 2028.
That's the bull case. And the stock trades at an $18 billion market cap, or 82 times trailing twelve-month sales. For context, that multiple assumes IonQ compounds revenue at roughly 55% annually for the next four years and hits profitability on schedule. If it does, the stock isn't cheap - it's fairly valued.
GARP requires the stock to trade at a multiple below the growth rate, not a multiple that demands flawless execution. At 82x sales with no forward earnings multiple yet, this isn't a bargain. It's a growth stock at peak conviction pricing. The market has already voted "quantum is real" - the question is whether IonQ can grow fast enough to justify the premium.
2. Rigetti is a venture bet with a $5.6 billion price tag.
Rigetti Computing (NASDAQ: RGTI) reported Q1 2026 revenue of $4.4 million, up 199% year-over-year. The company has roughly $600 million in cash and burns about $80–85 million annually, giving it five to six years of runway. It delivered on-premises quantum processing units and rolled out a 108-qubit system.
Annualized, that's roughly $17.6 million in revenue. Against a $5.6 billion market cap, the stock trades at over 300 times annualized sales. The revenue growth percentage looks impressive until you realize it's growing from a base smaller than most SaaS companies' monthly burn. This isn't a misunderstood stock - it's an R&D lab with a ticker.
3. D-Wave has bookings growth but revenue in freefall - the classic pre-revenue trap.
D-Wave Quantum (NYSE: QBTS) reported 2,000% bookings growth in Q1 2026 while its revenue dropped 81%. Full-year 2025 revenue was $24.6 million, up 179% from the prior year, with a respectable 82.6% gross margin and 135 customers. The company sits on $884.5 million in cash. Net loss for 2025: $355.1 million.
The market cap: $7.1 billion. That's 289 times trailing sales. The bookings story is real - companies are committing to D-Wave's quantum annealing platform - but bookings don't show up as earnings until months or years later. A company losing $355 million a year at a $7 billion valuation is being priced on future promise, not present math.
4. Quantum Computing Inc. is a $2 billion cash hoard disguised as a quantum story.
QUBT reported $682,000 in revenue for all of 2025. It raised roughly $1.5 billion through a SPAC merger and sits on $737.9 million in cash with $1.62 billion in total assets. The market cap: $2.08 billion.
This is a cash-rich shell with a quantum name. The $682,000 in revenue is proof of concept, not a business. At 3,000+ times trailing sales, there's no valuation framework that makes this a GARP setup. The cash provides a floor, but a floor isn't a thesis.
The real question: when does this become a GARP play?
The competitor article is right that quantum has graduated from pure speculation. IonQ's revenue growth and backlog prove that. But graduation from speculation to valuation is one jump; graduation to a bargain is another.
The GARP setup arrives in one of two ways: (1) IonQ misses on growth or execution, the stock pulls back to the $40–$50 range, and the valuation compresses to something closer to 40–50x forward sales while the 55%+ CAGR trajectory remains intact; or (2) a different quantum name proves it can scale revenue at a fraction of the multiple IonQ commands, creating a peer-relative entry.
Neither has happened yet. The $18 billion vote of confidence in IonQ is genuine - but it's also a vote that prices in the entire bull case. The math doesn't lie: if you have to assume perfection to justify a price, you're not getting a discount on uncertainty. You're paying the premium for certainty.
The quantum story is real. The GARP setup isn't here yet.
The key risk for IonQ long-term: if quantum advantage timelines slip, or if hyperscalers decide to build quantum in-house rather than buy access, the contracted backlog may not convert at the assumed rate. Revenue growth from $130M to $638M by 2028 requires execution that hasn't been stress-tested at this scale.